1. What Is the Coagulation POC Market?
The Coagulation POC Market covers portable analysers measuring PT/INR, aPTT, ACT, and platelet function at the point of care for anticoagulation monitoring, cardiac surgery, and haemorrhage control. Coagulation POC encompasses handheld INR warfarin monitoring, cardiac surgery ACT analysers, ROTEM and TEG viscoelastic haemostasis analysers, and trauma coagulation POC. Market dynamics reflect direct oral anticoagulant monitoring driving coagulation POC innovation, ROTEM and TEG goal-directed haemostasis management demonstrating blood product reduction, and home INR monitoring enabling patient self-testing.
2. Coagulation POC Market Size & Forecast
3. Emerging Technologies
- Multiplexed coagulation POC analysers testing INR, aPTT, fibrinogen, and platelet function from a single sample are advancing as comprehensive tools. Growing adoption at ICU and anticoagulation clinics is driven by panel coagulation assessment efficiency requirements.
- DOAC-specific reversal monitoring POC tests enabling idarucizumab and andexanet alfa reversal titration are advancing. Growing adoption at emergency medicine is driven by DOAC reversal agent dosing guidance requirements.
- Platelet reactivity POC testing guiding dual antiplatelet therapy after coronary stent insertion are advancing. Growing adoption at interventional cardiology is driven by aspirin and P2Y12 response monitoring requirements.
- AI coagulation clinical decision support integrating POC results with patient anticoagulant dosing history are advancing. Growing adoption at anticoagulation management programmes is driven by therapeutic range optimisation requirements.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Point Of Care Chemistry Market.
4. Key Market Opportunity
The highest-value opportunity in the Coagulation POC Market is the cardiac surgery viscoelastic haemostasis sub-market, where TEG 6s and ROTEM Sigma blood product reduction ROI justifies device investment at high-volume cardiac programmes. Home INR self-testing creates a large recurring consumer revenue channel as warfarin patient base maintains home monitoring. Trauma coagulation POC creates a high-acuity clinical opportunity as damage control resuscitation protocol adoption drives ROTEM trauma deployment. Asia Pacific coagulation POC creates geographic expansion as Chinese and Indian cardiac surgery centre infrastructure and trauma programme adoption grows.
5. Top Companies in the Coagulation POC Market
The following organisations hold leading positions in the Coagulation POC Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Roche Diagnostics (CoaguChek)
- Haemonetics (TEG 6s)
- Instrumentation Laboratory (ROTEM Sigma)
- Siemens Healthineers (CLOT-PRO)
- Abbott (i-STAT Coag)
- Diagnostica Stago
- Accriva Diagnostics
- Gem Premier (IL)
- Helena Biosciences
- Shire (HEMOSTASIS)
6. Market Segmentation
The Coagulation POC Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Parameter | PT/INR ACT ROTEM-TEG aPTT Platelet Function Multi-parameter |
| By Setting | Home INR Self-Testing Cardiac Surgery Trauma and ICU Anticoagulation Clinic |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Coagulation POC Market trajectory over the forecast period:
Roche CoaguChek INRange Achieves 500,000 Active Home INR Self-Testing Patients.Roche CoaguChek INRange home INR monitoring system achieving 500,000 active self-testing warfarin patients in Europe and North America in 2024 demonstrates home coagulation POC at consumer scale. Home INR self-testing achieving 65 percent time-in-therapeutic-range versus 55 percent for clinic-based monitoring demonstrates the outcome benefit driving CoaguChek adoption.
Haemonetics TEG 6s Viscoelastic Haemostasis Achieves Standard-of-Care Status in Cardiac Surgery.Haemonetics TEG 6s thromboelastography achieving standard-of-care status in over 60 percent of US cardiac surgery programmes in 2024 demonstrates viscoelastic POC coagulation mainstream adoption. TEG 6s guided haemostasis management demonstrating 25 percent blood product transfusion reduction versus laboratory-based coagulation management demonstrates the cost and clinical benefit.
Instrumentation Laboratory ROTEM Sigma Achieves European Trauma Coagulation POC Market Leadership.Instrumentation Laboratory ROTEM Sigma achieving 40 percent European trauma centre POC coagulation market share in 2024 demonstrates ROTEM viscoelastic haemostasis leadership in trauma. ROTEM Sigma enabling damage control resuscitation protocol guidance within 5 minutes of trauma patient arrival demonstrates the point-of-care speed critical to trauma haemostasis management.
For related market intelligence, see the Immunoassay Market.
8. Segmental Analysis
By parameter, the Viscoelastic ROTEM-TEG Haemostasis segment dominated the Coagulation POC Market in 2025. Representing the fastest-growing revenue category as cardiac surgery and trauma adoption drives viscoelastic testing expansion. The PT/INR Home Self-Testing segment dominated by installed patient base as CoaguChek maintains warfarin patient monitoring scale.
By setting, Cardiac Surgery dominated in 2025 by per-test revenue, while Home Self-Testing dominated by test volume.
9. Regional Analysis
Regional demand patterns across the Coagulation POC Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Coagulation POC Market in 2025, holding 43.8% of the global market. Anticoagulation clinics, emergency departments, and hospital haematology programmes are deploying point-of-care coagulation testing systems to enable rapid measurement of PT/INR, aPTT, ACT, and platelet function in warfarin management and surgical settings. CMS reimbursement for anticoagulation monitoring and growing adoption of patient self-testing for warfarin management are encouraging investment in portable coagulation testing devices. High anticoagulated patient population, established haematology testing infrastructure, and strong demand for rapid coagulation results in emergency and surgical settings are generating regional demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 16.17% during the forecast period. Cardiology programmes, anticoagulation management services, and in vitro diagnostic companies across Germany, France, Italy, the Netherlands, and the Nordic countries are deploying point-of-care coagulation systems for anticoagulation monitoring and surgical setting applications. European atrial fibrillation management guidelines and growing adoption of direct oral anticoagulants requiring coagulation monitoring are encouraging investment in point-of-care coagulation testing infrastructure. Rising cardiovascular disease burden and increasing anticoagulation therapy use are generating demand for coagulation POC systems.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Coagulation POC Market was valued at USD 2.84 Bn in 2025 and is projected to reach USD 8.06 Bn by 2034, growing at a CAGR of 12.3% over the 2026–2034 forecast period.
The Coagulation POC Market is projected to grow at a CAGR of 12.3% from 2026 to 2034.
North America accounted for the largest share of the Coagulation POC Market in 2025, holding 43.8% of the global market.
The leading companies in the Coagulation POC Market include Roche Diagnostics (CoaguChek), Haemonetics (TEG 6s), Instrumentation Laboratory (ROTEM Sigma), Siemens Healthineers (CLOT-PRO), Abbott (i-STAT Coag), Diagnostica Stago, Accriva Diagnostics, Gem Premier (IL), Helena Biosciences, Shire (HEMOSTASIS).
Roche coaguchek inrange achieves 500,000 active home inr self-testing patients.
By parameter, the Viscoelastic ROTEM-TEG Haemostasis segment dominated the Coagulation POC Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.